Literature DB >> 8813121

Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors.

R Shridhar1, V Shridhar, X Wang, W Paradee, M Dugan, F Sarkar, C Wilke, T W Glover, V K Vaitkevicius, D I Smith.   

Abstract

FRA3B, at chromosomal band 3p14.2, is the most active common fragile site in the human genome. Homozygous deletions in the region of FRA3B have been observed in many types of solid tumors. Recently, the FHIT gene was reported to span FRA3B and was shown to be homozygously deleted in several gastric and colonic tumor cell lines. Several microsatellite markers that precisely define the 1.0-Mb region surrounding FRA3B and FHIT have been utilized, along with other 3p microsatellites, to analyze the loss of 3p sequences in 25 primary pancreatic adenocarcinomas. The high density of microsatellite markers in the 3pl4.2 region enabled us to both identify losses within and flanking FRA3B in pancreatic cancer and define the breakpoints. We observed loss of het erozygosity of 3pl4.2 markers in 16 of 25 pancreatic tumors and loss of heterozygosity of 3p markers outside of 3pl4.2 in only 2 of 25 tumors of this type. There appears to be a dramatic clustering of chromosomal breakpoints at 3pl4.2 in and immediately distal to FRA3B in pancreatic cancer. We detected no homozygous deletions in this region.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813121

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Potential roles of tumor suppressor genes and microsatellite instability in hepatocellular carcinogenesis in southern African blacks.

Authors:  Lewis R Roberts; Nicholas F LaRusso
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  A migration signature and plasma biomarker panel for pancreatic adenocarcinoma.

Authors:  Seetharaman Balasenthil; Nanyue Chen; Steven T Lott; Jinyun Chen; Jennifer Carter; William E Grizzle; Marsha L Frazier; Subrata Sen; Ann McNeill Killary
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-11

Review 3.  Common fragile genes and digestive tract cancers.

Authors:  Tamotsu Kuroki; Yoshitsugu Tajima; Jyunichiro Furui; Takashi Kanematsu
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Fhit down-regulation is an early event in pancreatic carcinogenesis.

Authors:  Matteo Fassan; Borislav Rusev; Vincenzo Corbo; Pierluigi Gasparini; Claudio Luchini; Caterina Vicentini; Andrea Mafficini; Salvatore Paiella; Roberto Salvia; Ivana Cataldo; Aldo Scarpa; Kay Huebner
Journal:  Virchows Arch       Date:  2017-03-13       Impact factor: 4.064

5.  Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins.

Authors:  C Brenner; P Garrison; J Gilmour; D Peisach; D Ringe; G A Petsko; J M Lowenstein
Journal:  Nat Struct Biol       Date:  1997-03

6.  Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.

Authors:  R Baffa; L G Gomella; A Vecchione; P Bassi; K Mimori; J Sedor; C M Calviello; M Gardiman; C Minimo; S E Strup; P A McCue; A J Kovatich; F Pagano; K Huebner; C M Croce
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion.

Authors:  H Inoue; H Ishii; H Alder; E Snyder; T Druck; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  Purification and crystallization of complexes modeling the active state of the fragile histidine triad protein.

Authors:  C Brenner; H C Pace; P N Garrison; A K Robinson; A Rosler; X H Liu; G M Blackburn; C M Croce; K Huebner; L D Barnes
Journal:  Protein Eng       Date:  1997-12

9.  Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype.

Authors:  H Ouyang; Lj Mou; C Luk; N Liu; J Karaskova; J Squire; M S Tsao
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

10.  Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.

Authors:  Mark Bloomston; Jeffrey Kneile; Matthew Butterfield; Mary Dillhoff; Peter Muscarella; E Christopher Ellison; W Scott Melvin; Carlo M Croce; Flavia Pichiorri; Kay Huebner; Wendy L Frankel
Journal:  Ann Surg Oncol       Date:  2009-05-12       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.